J Korean Assoc Pediatr Surg.  2013 Dec;19(2):73-80. 10.13029/jkaps.2013.19.2.73.

Pediatric Inguinal Hernia Surgery 2,230 Cases Performed with Ketamine and Lidocaine

• Joo JS
• Joo HH
• Joo IH

• KMID: 1961497
• DOI: http://doi.org/10.13029/jkaps.2013.19.2.73

Abstract

Ketamine is a safe and effective drug for pediatric anesthesia, sedation and analgesia. We hoped to identify that surgeons could operate a pediatric hernia with the ketamine anesthesia without general anesthesia. The study was a consecutive case series of 2230 inguinal hernia patients aged 1 months to 17 years in a Joo's day-surgical clinic during 11-year period. The patients had pediatric inguinal hernia surgery without general anesthesia under the day-surgery system. We retrospectively analyzed the medical record of patients who were registered with the Diagnosis Related Group (DRG) system. All patients received ketamine (5mg/kg) and atropine (0.01mg/kg) intramuscularly before surgery. After anesthesia, we injected 1~2% lidocaine (Less than 5ml) subcutaneously at the site of incision and started operation. The surgical method was the high ligation method of the hernia sac.) In total 2230 patients, male were 1756 and female were 474. 2076 patients were a unilateral inguinal hernia at the time of surgery and 154 were bilateral hernia patients. Less than three months, depending on the age of the patients was 391, and less than 12 months the patient was 592 people (26.5%). After surgery, there were no accidents or long term complications associated with ketamine anesthesia. We think the surgeon can safely do the pediatric inguinal hernia surgery using ketamine and lidocaine without anesthesiologist through 11 years of our surgical experiences.

Keyword

Ketamine; Ketamine anesthesia; Pediatric inguinal hernia; Children; Surgery

MeSH Terms

Analgesia
Anesthesia
Anesthesia, General
Atropine
Child
Diagnosis
Female
Hernia
Hernia, Inguinal*
Hope
Humans
Ketamine*
Lidocaine*
Ligation
Male
Medical Records
Retrospective Studies
Atropine
Ketamine
Lidocaine

Reference

1. Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth. 1989; 03. 36(2):186–197.

2. Green SM, Rothrock SG, Lynch EL, Ho M, Harris T, Hestdalen R, Hopkins GA, Garrett W, Westcott K. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med. 1998; 06. 31(6):688–697.

3. Green SM, Hummel CB, Wittlake WA, Rothrock SG, Hopkins GA, Garrett W. What is the optimal dose of intra-muscular ketamine for pediatric sedation? Acad Emerg Med. 1999; 01. 6(1):21–26.

4. Bhutta AT. Ketamine: a controversial drug for neonates. Semin Perinatol. 2007; 10. 31(5):303–308.

5. Green SM, Rothrock SG, Harris T, Hopkins GA, Garrett W, Sherwin T. Intravenous ketamine for pediatric sedation in the emergency department: safety profile with 156 cases. Acad Emerg Med. 1998; 10. 5(10):971–976.

6. Lin C, Durieux ME. Ketamine and kids: an update. Paediatr Anaesth. 2005; 02. 15(2):91–97.

7. Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011; 05. 57(5):449–461.

8. Motoyama EK, Davis PJ, editors. Smith's Anesthesia for infants and Children. ed 6. St. Louis, MO: Mosby;1996.

9. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol. 1983; 06. 79(2):565–575.

10. MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH, Pennefather PS. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol. 1991; 01. 432:483–508.

11. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989; 29:365–402.

12. Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997; 04. 86(4):903–917.

13. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998; 11. 87(5):1186–1193.

14. Jobeir A, Galal MO, Bulbul ZR, Solymar L, Darwish A, Schmaltz AA. Use of low-dose ketamine and/or midazolam for pediatric cardiac catheterization. Pediatr Cardiol. 2003; 05-06. 24(3):236–243.

15. Mistry RB, Nahata MC. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy. 2005; 08. 25(8):1104–1111.

16. Vardi A, Salem Y, Padeh S, Paret G, Barzilay Z. Is propofol safe for procedural sedation in children? A prospective evaluation of propofol versus ketamine in pediatric critical care. Crit Care Med. 2002; 06. 30(6):1231–1236.

17. Jamora C, Iravani M. Unique clinical situations in pediatric patients where ketamine may be the anesthetic agent of choice. Am J Ther. 2010; 09-10. 17(5):511–515.

18. Green SM, Roback MG, Krauss B, Brown L, Mcglone RG, Agrawal D. Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med. 2009; 08. 54(2):158–168.

19. Green SM, Kuppermann N, Rothrock SG, Hummel CB, Ho M. Predictors of adverse events with intramuscular ketamine sedation in children. Ann Emerg Med. 2000; 01. 35(1):35–42.

20. Thorp AW, Brown L, Green SM. Ketamine-associated vomiting: is it dose-related? Pediatr Emerg Care. 2009; 01. 25(1):15–18.

21. Heinz P, Geelhoed GC, Wee C. Is atropine needed with ketamine sedation? A prospective, randomized, double blind study. Emerg Med J. 2006; 03. 23(3):206–209.

22. Brown L, Christian-Kopp Sarah. Adjunctive Atropine Is Unnecessary during Ketaine Sedation in Children. Acad Emerg Med. 2008; 04. 15(4):314–318.

23. Hara M, Kai Y, Ikemoto Y. Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology. 1993; 10. 79(4):781–788.

24. Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med. 2000; 12. 36(6):579–588.

25. Sherwin TS, Green SM, Khan A, Chapman DS, Dannenberg B. Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 2000; 03. 35(3):229–238.

26. Kennedy RM, McAllister JD. Midazolam with ketamine: who benefits? Ann Emerg Med. 2000; 03. 35(3):297–299.